Svafa Grönfeldt
Director/Board Member chez EMBLA MEDICAL HF.
Fortune : 95 875 $ au 31/03/2024
Profil
Svafa Grönfeldt is the founder of The MET Fund LLC.
She currently holds the following positions: Vice Chairman at Össur hf since 2008, Director at Marel hf since 2021, Director at Icelandair Group hf since 2019, and Professor at Massachusetts Institute of Technology since 2016.
She previously held positions as Deputy Chief Executive Officer at Actavis Group hf from 2002 to 2007, Director at Landsbankinn hf, Director at Origo hf from 2019 to 2021, Director at Alvogen, Inc. from 2010 to 2011, Managing Partner at Deloitte & Touche LLP, Assistant Professor at the University of Iceland, Member-Supervisory Board at Lotus Pharmaceutical Co., Ltd., and President at Reykjavik University from 2007 to 2010.
Dr. Grönfeldt's education includes a graduate degree from Florida Institute of Technology, Inc. and a doctorate degree from London School of Economics & Political Science.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ICELANDAIR GROUP HF
0,03% | 31/12/2023 | 12 500 000 ( 0,03% ) | 95 875 $ | 31/03/2024 |
Postes actifs de Svafa Grönfeldt
| Sociétés | Poste | Début |
|---|---|---|
| EMBLA MEDICAL HF. | Director/Board Member | 01/02/2008 |
| ICELANDAIR GROUP HF. | Director/Board Member | 08/03/2019 |
| MAREL HF. | Director/Board Member | 01/03/2021 |
The MET Fund LLC
 The MET Fund LLC Investment ManagersFinance The MET Fund LLC (MET Fund) is a venture capital firm founded in 2019 by Norbert Chang and Svafa Grönfeldt. The firm is headquartered in Boston. | Founder | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | 01/01/2021 |
Anciens postes connus de Svafa Grönfeldt
| Sociétés | Poste | Fin |
|---|---|---|
| ORIGO HF. | Director/Board Member | 01/01/2021 |
| Reykjavik University | President | 01/01/2010 |
Actavis Group hf
 Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Corporate Officer/Principal | 01/01/2007 |
| LOTUS PHARMACEUTICAL CO., LTD. | Director/Board Member | - |
| ░░░░░░░░ ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Svafa Grönfeldt
| Florida Institute of Technology, Inc. | Graduate Degree |
| London School of Economics & Political Science | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| EMBLA MEDICAL HF. | Health Technology |
| MAREL HF. | Producer Manufacturing |
| ORIGO HF. | Distribution Services |
| ICELANDAIR GROUP HF. | Transportation |
| LOTUS PHARMACEUTICAL CO., LTD. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Actavis Group hf
Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Health Technology |
Landsbankinn hf
 Landsbankinn hf Major BanksFinance Landsbankinn hf engages in the provision of banking and financial services. It operates through the following segments: Personal Banking, Corporate Banking, Markets, Treasury, and Support Functions. The Personal Banking segment provides financial services through the bank’s branch network to individuals and to small and medium-size businesses. The Corporate Banking offers financial services to corporate clients and to small and medium-size businesses. The Markets segment includes brokerage services in securities, foreign currencies and derivatives, securities offerings, and advisory services. The Treasury segment incorporates the bank’s funding and liquidity management, market making in money markets, and determines the bank’s internal pricing. The Support Functions segment consists of finance (excluding treasury), risk management, and information technology; as well as the chief executive officer's office which comprises of human resources, marketing and communications, and compliance. The company was founded in 1886 and is headquartered in Reykjavik, Iceland. | Finance |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Health Technology |
The MET Fund LLC
The MET Fund LLC Investment ManagersFinance The MET Fund LLC (MET Fund) is a venture capital firm founded in 2019 by Norbert Chang and Svafa Grönfeldt. The firm is headquartered in Boston. | Finance |
